Association of KIR3DS1+HLA-B BW4lle8 combination with susceptibility to tuberculosis in lur population of Iran

Iranian Journal of Immunology

Volumn 9, Issue 1, 2012, Pages 39-47

  Shahsavar, Farhad ^a   Mousavi, Tahereh ^b   Azargoon, Alireza ^a   Entezami, Kobra ^b  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hla; Kir; Nk cells; Tuberculosis

Indexed keywords

GENOMIC DNA; HLA B ANTIGEN; HLA B BW4 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA B BW4 GENE; HUMAN; INFECTION SENSITIVITY; IRAN; KIR3DS1 GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B ANTIGENS; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, KIR3DS1; TUBERCULOSIS; YOUNG ADULT;

EID: 84861661509     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rylance J, Pai M, Lienhardt C, Garner P. Priorities for tuberculosis research: a systematic review. Lancet Infect Dis. 2010; 10:886-892.
2. Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 2008; 10:995-1004.
3. Culley FJ. Natural killer cells in infection and inflammation of the lung. Immunology. 2009; 128:151-163.
4. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001; 19:197-223.
5. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, Sheer D, et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A. 2000; 97:4778-4783.
6. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, et al. Bethesda Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigenes. 2003; 62:79-86.
7. Single RM, Martin MP, Gao X, Meyer D, Yeager M, Kidd JR, et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet. 2007; 39: 1114-1119.
8. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002; 190:40-52.
9. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics. 2002; 54:221-229.
10. Rajalingam R. Killer Cell Immunoglobulin-Like Receptors Influence the Innate and Adaptive Immune Responses. Iran J Immunol. 2007; 4:61-78.
11. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005; 5:201-214.
12. Winter CC, Long EO. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol. 1997; 158:4026-4028.
13. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol. 1998; 161:571-577.
14. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med. 1994; 180:1235-1242.
15. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, et al. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol. 2007; 178:33-37.
16. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immu-noglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med. 1996; 184:505-518.
17. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1 2. J Immunol. 1996; 156:3098-3101.
18. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A. 2005; 102:13224-13229.
19. Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics. 2007; 59:1-15.
20. Ashouri E, Farjadian S, Reed EF, Ghaderi A, Rajalingam R. KIR gene content diversity in four Iranian populations. Immunogenetics. 2009; 61:483-492.
21. Tajik N, Shahsavar F, Mousavi T, Radjabzadeh MF. Distribution of KIR genes in the Iranian population. Tissue Antigens. 2009; 74:22-31.
22. Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. Int J Immnogenetics. 2010; 37:159-168.
23. Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, et al. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood. 2009; 113:426-432.
24. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Seminars in Immunology. 2008; 20:343-352.
25. Vejbaesya S, Chierakul N, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-alpha polymorphisms and susceptibility to tuberculosis in Thais. Respirology. 2007; 12:202-206.
26. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med. 2005; 201:1319-1332.
27. Tajik N, Shah-Hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, et al. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype. Tissue Antigens. 2012; 79:90-96.
28. Mousavi T, Farnia P, Tajik N, Soofi M. Elevation of CD56brightCD16- lymphocytes in MDR pulmonary tuberculosis. Iran J Immunol. 2010; 7:49-56.
29. Mousavi T, Shahsavar F, Farnia P, Tajik N, Soofi M. Study of KIR Expression and HLA Ligands in CD56+ Lymphocytes of Drug Resistant Tuberculosis Patients. Iran J Allergy Asthma Immunol. 2011; 10:189-194.
30. Velez DR, Hulme WF, Myers JL, Stryjewski ME, Abbate E, Estevan R, et al. Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians. Int J Tuberc Lung Dis. 2009; 13:1068-1076.
31. Velez DR, Hulme WF, Myers JL, Weinberg JB, Levesque MC, Stryjewski ME, et al. NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet. 2009; 126:643-653.
32. Mendez A, Granda H, Meenagh A, Contreras S, Zavaleta R, Mendoza MF, et al. Study of KIR genes in tuberculosis patients. Tissue Antigens. 2006; 68: 386-389.